Explore the significance of moral injury in health care and its impact on trust, especially during the Jewish High Holy Days.
News
New phase 3 data reveals seltorexant's potential as a safer adjunctive treatment for major depressive disorder with insomnia, despite not meeting its primary end point.
Esketamine nasal spray shows significant improvement in emotional blunting for treatment-resistant depression, offering hope for affected patients.
New study shows lumateperone (Caplyta) significantly improves symptoms in major depressive disorder with anxious distress, offering hope for treatment-resistant patients.
Poetry reflections with Dr Frank Clark.
Geriatric psychiatry faces a critical shortage of specialists, impacting the mental health care of the rapidly growing older adult population.
A groundbreaking trial reveals ANK3 as a potential genetic predictor for liafensine's effectiveness in treating resistant depression.
Effective psychiatric training empowers residents to take ownership of patient care, fostering confidence and critical thinking through real-world decision-making.
In clinical practice, there are individuals who have chronic low-grade hypomanic symptoms: high energy, need for less sleep than others, chronic optimism, and chronic risk-taking.
AI chatbots may assist in mental health, but they cannot replace the essential human connection provided by psychiatrists and therapists.
Psychiatrists advocate for mental health rights amid political turmoil, urging reconsideration of harmful health policies affecting vulnerable populations.
Onfasprodil shows promise as a rapid treatment for resistant depression, offering fewer side effects than ketamine in recent clinical trials.
Half of patients with stuttering also experience anxiety, highlighting the psychiatrist’s role in care and support.
FDA clears accelerated deep TMS protocol for major depressive disorder, offering faster treatment with similar outcomes and fewer visits.
Combining cognitive behavioral therapy with medication enhances ADHD treatment in adults, showing significant benefits within 3 months.
Adial Pharmaceuticals has received feedback from FDA on the AD04 phase 3 adaptive clinical trial design and broader clinical development strategy.
Peer mentoring enhances psychiatric care by supporting new providers, reducing burnout, and fostering collaboration among NPs and PAs in mental health.
Timing hormone replacement therapy post menopause significantly influences Alzheimer disease risk, with early treatment offering protective benefits against cognitive decline.
Chatbots engage youth with connection but pose serious risks, potentially harming mental health and fostering unhealthy attachments. Awareness and regulation are crucial.
"What they taught in school was not what we needed, and what we needed (they said) could not be conveyed."
Explore the impact of moral injuries on health care workers and the need for systemic change to support their well-being and mental health.
Discover effective strategies to build resilience and thrive through life's challenges, from personal growth to support systems and professional help.
New research highlights the effectiveness of early psychosis intervention programs, emphasizing low caseloads and clozapine access to reduce relapse rates.
Explore the evolving landscape of moral injury treatment in health care, emphasizing trust, advocacy, and innovative therapeutic approaches.
America is in the world, the world is in America.
Shelly Jo Kraft, MS, PhD, lays the foundation for a new approach that emphasizes the role of comorbidities in stuttering.
Collaborating with speech pathologists and others improve care for patients who stutter.
Gerald A. Maguire, MD, details the unmet needs in stuttering at the inaugural conference.
Simplistic explanations and convenient scapegoats belie the complexity of mass shootings.
